BioCentury | May 14, 2019
Distillery Therapeutics

Two generic antifungals and cerivastatin for biliary, pancreatic cancers

...that amoralfine, fenticonazole or cerivastatin could help treat intrahepatic cholangiocarcinoma (IHCC), gallbladder cancer, neuroendocrine carcinoma (NEC...
...derived from two other IHCC patients, one PDAC patient, one gallbladder cancer patient and one NEC...
BioCentury | Apr 25, 2019
Financial News

BostonGene raises $50M series A to develop personalized cancer therapy software

...A funds to scale and develop its cloud-based platform for determining optimal patient-specific cancer therapies. NEC Corp....
BioCentury | Aug 31, 2017
Targets & Mechanisms

Necroptosis strikes again

...to induce necroptosis." Proceedings of the National Academy of Sciences (2017) Yang, S.-H., et al. "Nec-1...
BioCentury | Jun 15, 2015
Company News

Prima BioMed, NEC, Yamaguchi University deal

...Prima, NEC and the university partnered to conduct a preclinical study of Prima’s IMP321 as an...
...study of Prima’s IMP321 as an adjuvant in combination with a peptide vaccine developed by NEC...
...and the university to treat hepatocellular cancer (HCC). The university will conduct the study, which NEC...
BioCentury | Nov 3, 2014
Company News

SomaLogic, NEC deal

...SomaLogic granted NEC exclusive rights in Japan to commercialize SomaLogic's SOMAscan proteomic assay. SOMAscan uses slow...
...detect and measure 1,129 protein concentrations in different biological sample types, including blood and tissue. NEC...
...the applications of SomaLogic's technology in the life sciences and healthcare markets. Under that deal, NEC...
BioCentury | May 16, 2013
Targets & Mechanisms

Raising the Ras inhibitor bar

...included researchers from the RIKEN SPring-8 Center , the Japan Synchrotron Radiation Research Institute and NEC Corp....
...Japan Kobe University , Kobe, Japan Kobe University Graduate School of Medicine , Kobe, Japan NEC Corp....
BioCentury | Aug 2, 2012
Targets & Mechanisms

New options for NEC

...In a newborn mouse model of NEC, daily enteral delivery of amniotic fluid significantly decreased NEC...
...anti-TLR4 effects of amniotic fluid and put newborns at risk for NEC. Newborn mice with NEC...
...initiating events of NEC and the later pathology effects in both the mouse and pig NEC...
BioCentury | Jul 19, 2012
Distillery Therapeutics

Indication: Gastrointestinal disease

...resolved NEC. Next steps include clinical trials of the amniotic fluid delivery strategy to prevent NEC...
BioCentury | Jul 15, 2010
Distillery Techniques

Technology: Markers

...APOC2; APOCII) and serum amyloid A (SAA) as biomarkers of neonatal sepsis and necrotizing enterocolitis (NEC...
...neonatal infections more rapidly than current methods. In plasma from infants with neonatal sepsis or NEC...
BioCentury | Apr 13, 2009
Company News

Sigma-Tau S.p.A., Danisco deal

...Danisco's STP-206 , a biologic agent comprised of live bacteria to prevent necrotizing enterocolitis (NEC). NEC...
Items per page:
1 - 10 of 14
BioCentury | May 14, 2019
Distillery Therapeutics

Two generic antifungals and cerivastatin for biliary, pancreatic cancers

...that amoralfine, fenticonazole or cerivastatin could help treat intrahepatic cholangiocarcinoma (IHCC), gallbladder cancer, neuroendocrine carcinoma (NEC...
...derived from two other IHCC patients, one PDAC patient, one gallbladder cancer patient and one NEC...
BioCentury | Apr 25, 2019
Financial News

BostonGene raises $50M series A to develop personalized cancer therapy software

...A funds to scale and develop its cloud-based platform for determining optimal patient-specific cancer therapies. NEC Corp....
BioCentury | Aug 31, 2017
Targets & Mechanisms

Necroptosis strikes again

...to induce necroptosis." Proceedings of the National Academy of Sciences (2017) Yang, S.-H., et al. "Nec-1...
BioCentury | Jun 15, 2015
Company News

Prima BioMed, NEC, Yamaguchi University deal

...Prima, NEC and the university partnered to conduct a preclinical study of Prima’s IMP321 as an...
...study of Prima’s IMP321 as an adjuvant in combination with a peptide vaccine developed by NEC...
...and the university to treat hepatocellular cancer (HCC). The university will conduct the study, which NEC...
BioCentury | Nov 3, 2014
Company News

SomaLogic, NEC deal

...SomaLogic granted NEC exclusive rights in Japan to commercialize SomaLogic's SOMAscan proteomic assay. SOMAscan uses slow...
...detect and measure 1,129 protein concentrations in different biological sample types, including blood and tissue. NEC...
...the applications of SomaLogic's technology in the life sciences and healthcare markets. Under that deal, NEC...
BioCentury | May 16, 2013
Targets & Mechanisms

Raising the Ras inhibitor bar

...included researchers from the RIKEN SPring-8 Center , the Japan Synchrotron Radiation Research Institute and NEC Corp....
...Japan Kobe University , Kobe, Japan Kobe University Graduate School of Medicine , Kobe, Japan NEC Corp....
BioCentury | Aug 2, 2012
Targets & Mechanisms

New options for NEC

...In a newborn mouse model of NEC, daily enteral delivery of amniotic fluid significantly decreased NEC...
...anti-TLR4 effects of amniotic fluid and put newborns at risk for NEC. Newborn mice with NEC...
...initiating events of NEC and the later pathology effects in both the mouse and pig NEC...
BioCentury | Jul 19, 2012
Distillery Therapeutics

Indication: Gastrointestinal disease

...resolved NEC. Next steps include clinical trials of the amniotic fluid delivery strategy to prevent NEC...
BioCentury | Jul 15, 2010
Distillery Techniques

Technology: Markers

...APOC2; APOCII) and serum amyloid A (SAA) as biomarkers of neonatal sepsis and necrotizing enterocolitis (NEC...
...neonatal infections more rapidly than current methods. In plasma from infants with neonatal sepsis or NEC...
BioCentury | Apr 13, 2009
Company News

Sigma-Tau S.p.A., Danisco deal

...Danisco's STP-206 , a biologic agent comprised of live bacteria to prevent necrotizing enterocolitis (NEC). NEC...
Items per page:
1 - 10 of 14